Sustained Release Excipients Market Size, Share & Trends Analysis Report By Route Of Administration (Oral, Transdermal), By Technology (Transdermal, Implants), By Product (Gelatin, Sugars), And Segment Forecasts, 2022 - 2030
This report can be delivered to the clients within 3 Business Days
Sustained Release Excipients Market Growth & Trends
The global sustained release excipients market size is expected to reach USD 2.4 billion by 2030, registering a CAGR of 8.22% over the forecast period, according to a new report by Grand View Research, Inc. Rise in the number of patent expirations, need for pediatric & geriatric dosage forms, and added benefits provided by sustained release formulations are factors that are positively contributing to the market potential. Sustained release formulations significantly reduce dosage frequency and improve patient compliance. These factors are further aiding industry growth. In comparison to conventional drugs, sustained drug release technologies provide a wide range of benefits.
Reduced dosage frequency, improved patient compliance, maintenance of the constant level of drug in blood plasma, lower instances of toxicity due to overdose, and higher cost-effectiveness, in the long run, are some of the major advantages of using sustained release drug delivery systems. Regular consumption of oral conventional drugs generally results in undesired symptoms, such as gastrointestinal upset, cramps, nausea, and diarrhea. The use of sustained release drug formulations provides patients relief from these symptoms and helps maintain desired therapeutic drug levels in the body. Moreover, these have been increasing the adoption of sustained release formulations, enabling higher patient compliance and improved therapeutic effect.
Over the past few years, there has been a global rise in antibiotic resistance. Overuse and misuse of conventional drug formulations have been identified as the major cause of antibiotic resistance. In some instances, patients recover within a few days of drug administration and discontinue the recommended dose of drugs, culminating in resistance. Such resistance leads to higher medical costs, longer hospital stays, and a rise in mortality rate. The rise in the incidence of infectious and chronic diseases has also resulted in antibiotic resistance, which has negatively impacted the conventional dosage forms market. Thus, alternative procedures to treat and manage these diseases are being implemented.
The use of controlled release formulations has been extensively accepted among physicians to prevent antibiotic resistance. Since these formulations generate preferred therapeutic drug levels in blood plasma and decrease the dosage frequency, they are an ideal choice of formulations among physicians, which increases their demand in the industry. The impact of disruptions on pharmaceutical production and subsequently on excipient demand affected by lockdowns and transport and travel bans across several countries due to the COVID-19 pandemic will be comparatively short-term. However, the supply disruptions due to extended lockdowns in different countries may have a more substantial impact on the oral solid dosage form drug manufacturing.
This, in turn, will significantly impact the excipients' demand growth globally. There is a wide scope for growth of the industry in Europe, which includes France, Spain, and Italy. This is due to the rising adoption of advanced drugs in these countries. Moreover, regulatory authorities, such as the European Medicines Agency (EMA) and Medicines & Healthcare Products Regulatory Agency (MHRA), are constantly working toward ensuring high safety standards and easy access to low-cost drugs in this region. High disposable income, the presence of sophisticated healthcare infrastructure, and a rise in the number of product approvals are the factors expected to create growth opportunities in the Europe region.
Sustained release formulations are designed specifically in ways to reduce the dosage frequency. Thus, these formulations have high Active Pharmaceutical Ingredient (API) doses, which facilitate the maintenance of desired therapeutic levels. However, drug toxicity resulting from sustained release formulations is difficult to treat due to excess API. Drug retrieval in these cases becomes difficult as drugs are designed to deliver predetermined amounts at frequent time intervals. These are very rarely seen in sustained release formulations, which may hinder industry growth to a certain extent.
Sustained Release Excipients Market Report Highlights
Sustained Release Excipients Market Growth & Trends
The global sustained release excipients market size is expected to reach USD 2.4 billion by 2030, registering a CAGR of 8.22% over the forecast period, according to a new report by Grand View Research, Inc. Rise in the number of patent expirations, need for pediatric & geriatric dosage forms, and added benefits provided by sustained release formulations are factors that are positively contributing to the market potential. Sustained release formulations significantly reduce dosage frequency and improve patient compliance. These factors are further aiding industry growth. In comparison to conventional drugs, sustained drug release technologies provide a wide range of benefits.
Reduced dosage frequency, improved patient compliance, maintenance of the constant level of drug in blood plasma, lower instances of toxicity due to overdose, and higher cost-effectiveness, in the long run, are some of the major advantages of using sustained release drug delivery systems. Regular consumption of oral conventional drugs generally results in undesired symptoms, such as gastrointestinal upset, cramps, nausea, and diarrhea. The use of sustained release drug formulations provides patients relief from these symptoms and helps maintain desired therapeutic drug levels in the body. Moreover, these have been increasing the adoption of sustained release formulations, enabling higher patient compliance and improved therapeutic effect.
Over the past few years, there has been a global rise in antibiotic resistance. Overuse and misuse of conventional drug formulations have been identified as the major cause of antibiotic resistance. In some instances, patients recover within a few days of drug administration and discontinue the recommended dose of drugs, culminating in resistance. Such resistance leads to higher medical costs, longer hospital stays, and a rise in mortality rate. The rise in the incidence of infectious and chronic diseases has also resulted in antibiotic resistance, which has negatively impacted the conventional dosage forms market. Thus, alternative procedures to treat and manage these diseases are being implemented.
The use of controlled release formulations has been extensively accepted among physicians to prevent antibiotic resistance. Since these formulations generate preferred therapeutic drug levels in blood plasma and decrease the dosage frequency, they are an ideal choice of formulations among physicians, which increases their demand in the industry. The impact of disruptions on pharmaceutical production and subsequently on excipient demand affected by lockdowns and transport and travel bans across several countries due to the COVID-19 pandemic will be comparatively short-term. However, the supply disruptions due to extended lockdowns in different countries may have a more substantial impact on the oral solid dosage form drug manufacturing.
This, in turn, will significantly impact the excipients' demand growth globally. There is a wide scope for growth of the industry in Europe, which includes France, Spain, and Italy. This is due to the rising adoption of advanced drugs in these countries. Moreover, regulatory authorities, such as the European Medicines Agency (EMA) and Medicines & Healthcare Products Regulatory Agency (MHRA), are constantly working toward ensuring high safety standards and easy access to low-cost drugs in this region. High disposable income, the presence of sophisticated healthcare infrastructure, and a rise in the number of product approvals are the factors expected to create growth opportunities in the Europe region.
Sustained release formulations are designed specifically in ways to reduce the dosage frequency. Thus, these formulations have high Active Pharmaceutical Ingredient (API) doses, which facilitate the maintenance of desired therapeutic levels. However, drug toxicity resulting from sustained release formulations is difficult to treat due to excess API. Drug retrieval in these cases becomes difficult as drugs are designed to deliver predetermined amounts at frequent time intervals. These are very rarely seen in sustained release formulations, which may hinder industry growth to a certain extent.
Sustained Release Excipients Market Report Highlights
- The polymers product segment accounted for the largest share in 2021. Varied usage of polymers in sustained release formulations is anticipated to fuel industry growth
- Conventional use of the oral route of delivery has contributed to the segment's growth. Convenience, in terms of storage, premeasured doses, portability, and noninvasive nature of this route are some of the major factors accelerating its adoption
- The rising adoption of transdermal patches has contributed to the growth of the segment
- Targeted drug delivery constituted the largest revenue share in 2021, as a large number of industry players have strong product portfolios. Implantable sustained release drug delivery systems have improved efficiency, lower adverse effects, and higher convenience, which impels segment growth
- Europe dominated the global industry in 2021 due to the high investments in R&D and availability of highly sophisticated technologies in the region
- Asia Pacific will register the fastest CAGR during the forecast period due to the growing pharmaceutical industry in emerging countries, such as India and China
CHAPTER 1 RESEARCH METHODOLOGY
1.1 Market Segmentation & Scope
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity flow approach
1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
1.7 Global Market: CAGR Calculation
1.8 Research Assumptions
1.9 List of Secondary Sources
1.10 List of Primary Sources
1.11 Objectives
1.11.1 Objective 1:
1.11.2 Objective 2:
1.12 List of Abbreviations
CHAPTER 2 MARKET DEFINITIONS
CHAPTER 3 EXECUTIVE SUMMARY
3.1 Market Summary
CHAPTER 4 GLOBAL SUSTAINED RELEASE EXCIPIENTS MARKET VARIABLES, TRENDS, & SCOPE
4.1 Sustained Release Excipients Market Lineage Outlook
4.1.1 Parent Market Outlook
4.2 Penetration and Growth Prospect Mapping
4.3 Regulatory Framework
4.4 Market Driver Analysis
4.4.1 Increased Benefits Over Conventional Dosage Forms
4.4.2 Increased Acceptance Due To Nature Of Dosage Forms
4.4.3 Necessity Of Pediatric And Geriatric Sustained Release Dosage Forms
4.4.4 Antibiotic Resistance
4.5 Market Restraint Analysis
4.5.1 Drug Toxicity Due To Dose Dumping
4.5.2 Need For High Dose Of API
4.6 Market Challenge Analysis
4.6.1 Patient Education And Counselling
4.6.2 Higher Cost Of Sustained Release Systems In Comparison To Conventional Pharmaceutical Formulations
4.7 Key Opportunities
4.7.1 Minimization Of Hepatic First Pass Elimination
4.7.1 Development Cost-Efficient Dosage Forms
4.8 Sustained Release Excipients Market - PESTLE analysis
4.9 Industry Analysis - Porter’s
4.10 Major Deals and Strategic Alliances Analysis
4.10.1 Joint Ventures
4.10.2 Mergers And Acquisitions
4.10.3 Licensing And Partnership
4.10.4 Technology Collaborations
4.10.5 Strategic Divestments
4.11 Covid-19 Impact Analysis
CHAPTER 5 SUSTAINED RELEASE EXCIPIENTS MARKET - SEGMENT ANALYSIS, BY PRODUCT, 2018 - 2030 (USD MILLION)
5.1 Global Sustained Release Excipients Market: Product Movement Analysis
5.2 Gelatin
5.2.1 Gelatin Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.3 Polymers
5.3.1 Polymers Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.4 Minerals
5.4.1 Minerals Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.5 Sugars
5.5.1 Sugars Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.6 Alcohol
5.6.1 Alcohol Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.7 Chitosan
5.7.1 Chitosan Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 6 SUSTAINED RELEASE EXCIPIENTS MARKET- SEGMENT ANALYSIS, BY ROUTE OF ADMINISTRATION, 2018 - 2030 (USD MILLION)
6.1 Sustained Release Excipients Market: Route Of Administration Movement Analysis
6.2 Oral
6.2.1 Oral Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3 Intramuscular
6.3.1 Intramuscular Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4 Subcutaneous
6.4.1 Subcutaneous Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.5 Transdermal
6.5.1 Transdermal Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.6 Vaginal
6.6.1 Vaginal Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.6 Ophthalmic
6.6.1 Ophthalmic Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.7 Intravenous
6.7.1 Intravenous Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.8 Others
6.8.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 7 SUSTAINED RELEASE EXCIPIENTS MARKET - SEGMENT ANALYSIS, BY TECHNOLOGY, 2018 - 2030 (USD MILLION)
7.1 Global Sustained Release Excipients Market: Technology Movement Analysis
7.2 Targeted Delivery
7.2.1 Targeted Delivery Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.3 Microencapsulation
7.3.1 Microencapsulation Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.4 Wurster Technique
7.4.1 Wurster Technique Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.5 Transdermal
7.5.1 Transdermal Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.6 Implants
7.6.1 Implants Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.7 Coacervation
7.7.1 Coacervation Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.8 Others
7.8.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 8 SUSTAINED RELEASE EXCIPIENTS MARKET: - SEGMENT ANALYSIS, BY REGION, 2018 - 2030 (USD MILLION)
8.1 Sustained Release Excipients Market: Regional Movement Analysis
8.2 North America
8.2.1 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.2.2 U.S.
8.2.2.1 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.2.3 Canada
8.2.3.1 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3 Europe
8.3.1 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.2 U.K.
8.3.2.1 U.K. Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.3. Germany
8.3.3.1 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.4 France
8.3.4.1 France Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.5. Italy
8.3.5.1 Italy Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.5 Spain
8.3.5.1 Spain Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4 Asia Pacific
8.4.1 Asia Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4.2 Japan
8.4.2.1 Japan Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4.3 China
8.4.3.1 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4.4 India
8.4.4.1 India Market Estimates And Forecast, 2018-2030
8.4.5 South Korea
8.4.5.1 South Korea Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4.6 Australia
8.4.6.1 Australia Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.5 Latin America
8.5.1 Latin America Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.5.2 Brazil
8.5.2.1 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.5.3 Mexico
8.5.3.1 Mexico Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.5.4 Argentina
8.5.4.1 Argentina Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.6 Middle East & Africa (MEA)
8.6.1 Middle East & Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.6.2 South Africa
8.6.2.1 South Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.6.3 Saudi Arabia
8.6.3.1 Saudi Arabia Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.6.4 UAE
8.6.4.1 UAE Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 9 COMPETITIVE LANDSCAPE
9.1 Public Companies
9.1.1 Company Market Position Analysis
9.1.2 Competitive Dashboard Analysis
9.1.3 Strategic Framework
9.2 Private Companies
9.2.1 List Of Key Emerging Companies/Technology Disruptors/Innovators
9.2.2 Regional Network Map
9.3 Company Profiles: Sustained Release Drugs
9.3.1 TEVA PHARMACEUTICAL INDUSTRIES LTD.
9.3.1.1 Company Overview
9.3.1.2 Financial Performance
9.3.1.3 Product Benchmarking
9.3.1.4 Strategic Initiatives
9.3.2 MYLAN N.V.
9.3.2.1 Company Overview
9.3.2.2 Financial Performance
9.3.2.3 Product Benchmarking
9.3.2.4 Strategic Initiatives
9.3.3 VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
9.3.3.1 Company Overview
9.3.3.2 Financial Performance
9.3.3.3 Product Benchmarking
9.3.3.4 Strategic Initiatives
9.3.4 PFIZER, INC.
9.3.4.1 Company Overview
9.3.4.2 Financial Performance
9.3.4.3 Product Benchmarking
9.3.4.4 Strategic Initiatives
9.3.5 SUN PHARMACEUTICAL INDUSTRIES LTD.
9.3.5.1 Company Overview
9.3.5.2 Financial Performance
9.3.5.3 Product Benchmarking
9.3.5.4 Strategic Initiatives
9.3.6 NOVARTIS AG
9.3.6.1 Company Overview
9.3.6.2 Financial Performance
9.3.6.3 Product Benchmarking
9.3.6.4 Strategic Initiatives
9.3.7 ASTRAZENECA
9.3.7.1 Company Overview
9.3.7.2 Financial Performance
9.3.7.3 Product Benchmarking
9.3.7.4 Strategic Initiatives
9.3.8 GLAXOSMITHKLINE PLC
9.3.8.1 Company Overview
9.3.8.2 Financial Performance
9.3.8.3 Product Benchmarking
9.3.8.4 Strategic Initiatives
9.3.9 ALLERGAN PLC
9.3.9.1 Company Overview
9.3.9.2 Financial Performance
9.3.9.3 Product Benchmarking
9.3.9.4 Strategic Initiatives
9.3.10 JANSSEN PHARMACEUTICALS, INC.
9.3.10.1 Company Overview
9.3.10.2 Financial Performance
9.3.10.3 Product Benchmarking
9.3.10.4 Strategic Initiatives
9.3.11 MAYNE PHARMA GROUP LIMITED
9.3.11.1 Company Overview
9.3.11.2 Financial Performance
9.3.11.3 Product Benchmarking
9.3.11.4 Strategic Initiatives
9.4 Company Profiles: Sustained Release Technology
9.4.1 Croda International Plc
9.4.1.1 Company Overview
9.4.1.2 Financial Performance
9.4.1.3 Product Benchmarking
9.4.1.4 Strategic Initiatives
9.4.2 Merck KGaA
9.4.2.1 Company Overview
9.4.2.2 Financial Performance
9.4.2.3 Product Benchmarking
9.4.2.4 Strategic Initiatives
9.4.3 BASF
9.4.3.1 Company Overview
9.4.3.2 Financial Performance
9.4.3.3 Product Benchmarking
9.4.3.4 Strategic Initiatives
9.4.4 Ashland Global
9.4.4.1 Company Overview
9.4.4.2 Financial Performance
9.4.4.3 Product Benchmarking
9.4.4.5 Strategic Initiatives
9.4.5 International Flavors & Fragrances, Inc.
9.4.5.1 Company Overview
9.4.5.2 Financial Performance
9.4.5.3 Product Benchmarking
9.4.5.4 Strategic Initiatives
9.4.6 Evonik Industries
9.4.6.1 Company Overview
9.4.6.2 Financial Performance
9.4.6.3 Product Benchmarking
9.4.6.4 Strategic Initiatives
9.5.7 Gattefoss?
9.5.7.1 Company Overview
9.5.7.2 Financial Performance
9.5.7.3 Product Benchmarking
9.5.7.4 Strategic Initiatives
1.1 Market Segmentation & Scope
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity flow approach
1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
1.7 Global Market: CAGR Calculation
1.8 Research Assumptions
1.9 List of Secondary Sources
1.10 List of Primary Sources
1.11 Objectives
1.11.1 Objective 1:
1.11.2 Objective 2:
1.12 List of Abbreviations
CHAPTER 2 MARKET DEFINITIONS
CHAPTER 3 EXECUTIVE SUMMARY
3.1 Market Summary
CHAPTER 4 GLOBAL SUSTAINED RELEASE EXCIPIENTS MARKET VARIABLES, TRENDS, & SCOPE
4.1 Sustained Release Excipients Market Lineage Outlook
4.1.1 Parent Market Outlook
4.2 Penetration and Growth Prospect Mapping
4.3 Regulatory Framework
4.4 Market Driver Analysis
4.4.1 Increased Benefits Over Conventional Dosage Forms
4.4.2 Increased Acceptance Due To Nature Of Dosage Forms
4.4.3 Necessity Of Pediatric And Geriatric Sustained Release Dosage Forms
4.4.4 Antibiotic Resistance
4.5 Market Restraint Analysis
4.5.1 Drug Toxicity Due To Dose Dumping
4.5.2 Need For High Dose Of API
4.6 Market Challenge Analysis
4.6.1 Patient Education And Counselling
4.6.2 Higher Cost Of Sustained Release Systems In Comparison To Conventional Pharmaceutical Formulations
4.7 Key Opportunities
4.7.1 Minimization Of Hepatic First Pass Elimination
4.7.1 Development Cost-Efficient Dosage Forms
4.8 Sustained Release Excipients Market - PESTLE analysis
4.9 Industry Analysis - Porter’s
4.10 Major Deals and Strategic Alliances Analysis
4.10.1 Joint Ventures
4.10.2 Mergers And Acquisitions
4.10.3 Licensing And Partnership
4.10.4 Technology Collaborations
4.10.5 Strategic Divestments
4.11 Covid-19 Impact Analysis
CHAPTER 5 SUSTAINED RELEASE EXCIPIENTS MARKET - SEGMENT ANALYSIS, BY PRODUCT, 2018 - 2030 (USD MILLION)
5.1 Global Sustained Release Excipients Market: Product Movement Analysis
5.2 Gelatin
5.2.1 Gelatin Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.3 Polymers
5.3.1 Polymers Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.4 Minerals
5.4.1 Minerals Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.5 Sugars
5.5.1 Sugars Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.6 Alcohol
5.6.1 Alcohol Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.7 Chitosan
5.7.1 Chitosan Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 6 SUSTAINED RELEASE EXCIPIENTS MARKET- SEGMENT ANALYSIS, BY ROUTE OF ADMINISTRATION, 2018 - 2030 (USD MILLION)
6.1 Sustained Release Excipients Market: Route Of Administration Movement Analysis
6.2 Oral
6.2.1 Oral Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3 Intramuscular
6.3.1 Intramuscular Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4 Subcutaneous
6.4.1 Subcutaneous Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.5 Transdermal
6.5.1 Transdermal Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.6 Vaginal
6.6.1 Vaginal Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.6 Ophthalmic
6.6.1 Ophthalmic Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.7 Intravenous
6.7.1 Intravenous Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.8 Others
6.8.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 7 SUSTAINED RELEASE EXCIPIENTS MARKET - SEGMENT ANALYSIS, BY TECHNOLOGY, 2018 - 2030 (USD MILLION)
7.1 Global Sustained Release Excipients Market: Technology Movement Analysis
7.2 Targeted Delivery
7.2.1 Targeted Delivery Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.3 Microencapsulation
7.3.1 Microencapsulation Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.4 Wurster Technique
7.4.1 Wurster Technique Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.5 Transdermal
7.5.1 Transdermal Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.6 Implants
7.6.1 Implants Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.7 Coacervation
7.7.1 Coacervation Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.8 Others
7.8.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 8 SUSTAINED RELEASE EXCIPIENTS MARKET: - SEGMENT ANALYSIS, BY REGION, 2018 - 2030 (USD MILLION)
8.1 Sustained Release Excipients Market: Regional Movement Analysis
8.2 North America
8.2.1 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.2.2 U.S.
8.2.2.1 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.2.3 Canada
8.2.3.1 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3 Europe
8.3.1 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.2 U.K.
8.3.2.1 U.K. Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.3. Germany
8.3.3.1 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.4 France
8.3.4.1 France Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.5. Italy
8.3.5.1 Italy Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.5 Spain
8.3.5.1 Spain Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4 Asia Pacific
8.4.1 Asia Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4.2 Japan
8.4.2.1 Japan Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4.3 China
8.4.3.1 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4.4 India
8.4.4.1 India Market Estimates And Forecast, 2018-2030
8.4.5 South Korea
8.4.5.1 South Korea Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4.6 Australia
8.4.6.1 Australia Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.5 Latin America
8.5.1 Latin America Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.5.2 Brazil
8.5.2.1 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.5.3 Mexico
8.5.3.1 Mexico Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.5.4 Argentina
8.5.4.1 Argentina Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.6 Middle East & Africa (MEA)
8.6.1 Middle East & Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.6.2 South Africa
8.6.2.1 South Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.6.3 Saudi Arabia
8.6.3.1 Saudi Arabia Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.6.4 UAE
8.6.4.1 UAE Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 9 COMPETITIVE LANDSCAPE
9.1 Public Companies
9.1.1 Company Market Position Analysis
9.1.2 Competitive Dashboard Analysis
9.1.3 Strategic Framework
9.2 Private Companies
9.2.1 List Of Key Emerging Companies/Technology Disruptors/Innovators
9.2.2 Regional Network Map
9.3 Company Profiles: Sustained Release Drugs
9.3.1 TEVA PHARMACEUTICAL INDUSTRIES LTD.
9.3.1.1 Company Overview
9.3.1.2 Financial Performance
9.3.1.3 Product Benchmarking
9.3.1.4 Strategic Initiatives
9.3.2 MYLAN N.V.
9.3.2.1 Company Overview
9.3.2.2 Financial Performance
9.3.2.3 Product Benchmarking
9.3.2.4 Strategic Initiatives
9.3.3 VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
9.3.3.1 Company Overview
9.3.3.2 Financial Performance
9.3.3.3 Product Benchmarking
9.3.3.4 Strategic Initiatives
9.3.4 PFIZER, INC.
9.3.4.1 Company Overview
9.3.4.2 Financial Performance
9.3.4.3 Product Benchmarking
9.3.4.4 Strategic Initiatives
9.3.5 SUN PHARMACEUTICAL INDUSTRIES LTD.
9.3.5.1 Company Overview
9.3.5.2 Financial Performance
9.3.5.3 Product Benchmarking
9.3.5.4 Strategic Initiatives
9.3.6 NOVARTIS AG
9.3.6.1 Company Overview
9.3.6.2 Financial Performance
9.3.6.3 Product Benchmarking
9.3.6.4 Strategic Initiatives
9.3.7 ASTRAZENECA
9.3.7.1 Company Overview
9.3.7.2 Financial Performance
9.3.7.3 Product Benchmarking
9.3.7.4 Strategic Initiatives
9.3.8 GLAXOSMITHKLINE PLC
9.3.8.1 Company Overview
9.3.8.2 Financial Performance
9.3.8.3 Product Benchmarking
9.3.8.4 Strategic Initiatives
9.3.9 ALLERGAN PLC
9.3.9.1 Company Overview
9.3.9.2 Financial Performance
9.3.9.3 Product Benchmarking
9.3.9.4 Strategic Initiatives
9.3.10 JANSSEN PHARMACEUTICALS, INC.
9.3.10.1 Company Overview
9.3.10.2 Financial Performance
9.3.10.3 Product Benchmarking
9.3.10.4 Strategic Initiatives
9.3.11 MAYNE PHARMA GROUP LIMITED
9.3.11.1 Company Overview
9.3.11.2 Financial Performance
9.3.11.3 Product Benchmarking
9.3.11.4 Strategic Initiatives
9.4 Company Profiles: Sustained Release Technology
9.4.1 Croda International Plc
9.4.1.1 Company Overview
9.4.1.2 Financial Performance
9.4.1.3 Product Benchmarking
9.4.1.4 Strategic Initiatives
9.4.2 Merck KGaA
9.4.2.1 Company Overview
9.4.2.2 Financial Performance
9.4.2.3 Product Benchmarking
9.4.2.4 Strategic Initiatives
9.4.3 BASF
9.4.3.1 Company Overview
9.4.3.2 Financial Performance
9.4.3.3 Product Benchmarking
9.4.3.4 Strategic Initiatives
9.4.4 Ashland Global
9.4.4.1 Company Overview
9.4.4.2 Financial Performance
9.4.4.3 Product Benchmarking
9.4.4.5 Strategic Initiatives
9.4.5 International Flavors & Fragrances, Inc.
9.4.5.1 Company Overview
9.4.5.2 Financial Performance
9.4.5.3 Product Benchmarking
9.4.5.4 Strategic Initiatives
9.4.6 Evonik Industries
9.4.6.1 Company Overview
9.4.6.2 Financial Performance
9.4.6.3 Product Benchmarking
9.4.6.4 Strategic Initiatives
9.5.7 Gattefoss?
9.5.7.1 Company Overview
9.5.7.2 Financial Performance
9.5.7.3 Product Benchmarking
9.5.7.4 Strategic Initiatives
LIST OF TABLES
TABLE 1 List of Secondary Sources
TABLE 2 List of Abbreviations
TABLE 3 Global Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
TABLE 4 Global Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
TABLE 5 Global Sustained Release Excipients Market, Technology, 2018 - 2030 (USD Million)
TABLE 6 Global Sustained Release Excipients Market, by Region, 2018 - 2030 (USD Million)
TABLE 7 North America Sustained Release Excipients Market, by Country, 2018 - 2030 (USD Million)
TABLE 8 North America Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
TABLE 9 North America Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
TABLE 10 North America Sustained Release Excipients Market, Technology, 2018 - 2030 (USD Million)
TABLE 11 U.S. Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
TABLE 12 U.S. Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
TABLE 13 U.S. Sustained Release Excipients Market, Technology, 2018 - 2030 (USD Million)
TABLE 14 Canada Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
TABLE 15 Canada Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
TABLE 16 Canada Sustained Release Excipients Market, Technology, 2018 - 2030 (USD Million)
TABLE 17 Europe Sustained Release Excipients Market, by Country, 2018 - 2030 (USD Million)
TABLE 18 Europe Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
TABLE 19 Europe Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
TABLE 20 Europe Sustained Release Excipients Market, Technology, 2018 - 2030 (USD Million)
TABLE 21 Germany Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
TABLE 22 Germany Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
TABLE 23 Germany Sustained Release Excipients Market, Technology, 2018 - 2030 (USD Million)
TABLE 24 U.K. Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
TABLE 25 U.K. Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
TABLE 26 U.K. Sustained Release Excipients Market, Technology, 2018 - 2030 (USD Million)
TABLE 27 France Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
TABLE 28 France Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
TABLE 29 France Sustained Release Excipients Market, Technology, 2018 - 2030 (USD Million)
TABLE 30 Italy Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
TABLE 31 Italy Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
TABLE 32 Italy Sustained Release Excipients Market, Technology, 2018 - 2030 (USD Million)
TABLE 33 Spain Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
TABLE 34 Spain Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
TABLE 35 Spain Sustained Release Excipients Market, Technology, 2018 - 2030 (USD Million)
TABLE 36 Asia Pacific Sustained Release Excipients Market, by Country, 2018 - 2030 (USD Million)
TABLE 37 Asia Pacific Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
TABLE 38 Asia Pacific Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
TABLE 39 Asia Pacific Sustained Release Excipients Market, Technology, 2018 - 2030 (USD Million)
TABLE 40 China Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
TABLE 41 China Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
TABLE 42 China Sustained Release Excipients Market, Technology, 2018 - 2030 (USD Million)
TABLE 43 Japan Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
TABLE 44 Japan Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
TABLE 45 Japan Sustained Release Excipients Market, Technology, 2018 - 2030 (USD Million)
TABLE 46 India Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
TABLE 47 India Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
TABLE 48 India Sustained Release Excipients Market, Technology, 2018 - 2030 (USD Million)
TABLE 49 South Korea Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
TABLE 50 South Korea Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
TABLE 51 South Korea Sustained Release Excipients Market, Technology, 2018 - 2030 (USD Million)
TABLE 52 Australia Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
TABLE 53 Australia Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
TABLE 54 Australia Sustained Release Excipients Market, Technology, 2018 - 2030 (USD Million)
TABLE 55 Latin America Sustained Release Excipients Market, by Country, 2018 - 2030 (USD Million)
TABLE 56 Latin America Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
TABLE 57 Latin America Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
TABLE 58 Latin America Sustained Release Excipients Market, Technology, 2018 - 2030 (USD Million)
TABLE 59 Brazil Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
TABLE 60 Brazil Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
TABLE 61 Brazil Sustained Release Excipients Market, Technology, 2018 - 2030 (USD Million)
TABLE 62 Mexico Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
TABLE 63 Mexico Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
TABLE 64 Mexico Sustained Release Excipients Market, Technology, 2018 - 2030 (USD Million)
TABLE 65 Argentina Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
TABLE 66 Argentina Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
TABLE 67 Argentina Sustained Release Excipients Market, Technology, 2018 - 2030 (USD Million)
TABLE 68 Middle East & Africa Sustained Release Excipients Market, by Country, 2018 - 2030 (USD Million)
TABLE 69 Middle East & Africa Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
TABLE 70 Middle East & Africa Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
TABLE 71 Middle East & Africa Sustained Release Excipients Market, Technology, 2018 - 2030 (USD Million)
TABLE 72 South Africa Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
TABLE 73 South Africa Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
TABLE 74 South Africa Sustained Release Excipients Market, Technology, 2018 - 2030 (USD Million)
TABLE 75 Saudi Arabia Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
TABLE 76 Saudi Arabia Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
TABLE 77 Saudi Arabia Sustained Release Excipients Market, Technology, 2018 - 2030 (USD Million)
TABLE 78 UAE Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
TABLE 79 UAE Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
TABLE 80 UAE Sustained Release Excipients Market, Technology, 2018 - 2030 (USD Million)
TABLE 1 List of Secondary Sources
TABLE 2 List of Abbreviations
TABLE 3 Global Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
TABLE 4 Global Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
TABLE 5 Global Sustained Release Excipients Market, Technology, 2018 - 2030 (USD Million)
TABLE 6 Global Sustained Release Excipients Market, by Region, 2018 - 2030 (USD Million)
TABLE 7 North America Sustained Release Excipients Market, by Country, 2018 - 2030 (USD Million)
TABLE 8 North America Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
TABLE 9 North America Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
TABLE 10 North America Sustained Release Excipients Market, Technology, 2018 - 2030 (USD Million)
TABLE 11 U.S. Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
TABLE 12 U.S. Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
TABLE 13 U.S. Sustained Release Excipients Market, Technology, 2018 - 2030 (USD Million)
TABLE 14 Canada Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
TABLE 15 Canada Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
TABLE 16 Canada Sustained Release Excipients Market, Technology, 2018 - 2030 (USD Million)
TABLE 17 Europe Sustained Release Excipients Market, by Country, 2018 - 2030 (USD Million)
TABLE 18 Europe Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
TABLE 19 Europe Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
TABLE 20 Europe Sustained Release Excipients Market, Technology, 2018 - 2030 (USD Million)
TABLE 21 Germany Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
TABLE 22 Germany Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
TABLE 23 Germany Sustained Release Excipients Market, Technology, 2018 - 2030 (USD Million)
TABLE 24 U.K. Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
TABLE 25 U.K. Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
TABLE 26 U.K. Sustained Release Excipients Market, Technology, 2018 - 2030 (USD Million)
TABLE 27 France Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
TABLE 28 France Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
TABLE 29 France Sustained Release Excipients Market, Technology, 2018 - 2030 (USD Million)
TABLE 30 Italy Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
TABLE 31 Italy Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
TABLE 32 Italy Sustained Release Excipients Market, Technology, 2018 - 2030 (USD Million)
TABLE 33 Spain Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
TABLE 34 Spain Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
TABLE 35 Spain Sustained Release Excipients Market, Technology, 2018 - 2030 (USD Million)
TABLE 36 Asia Pacific Sustained Release Excipients Market, by Country, 2018 - 2030 (USD Million)
TABLE 37 Asia Pacific Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
TABLE 38 Asia Pacific Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
TABLE 39 Asia Pacific Sustained Release Excipients Market, Technology, 2018 - 2030 (USD Million)
TABLE 40 China Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
TABLE 41 China Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
TABLE 42 China Sustained Release Excipients Market, Technology, 2018 - 2030 (USD Million)
TABLE 43 Japan Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
TABLE 44 Japan Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
TABLE 45 Japan Sustained Release Excipients Market, Technology, 2018 - 2030 (USD Million)
TABLE 46 India Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
TABLE 47 India Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
TABLE 48 India Sustained Release Excipients Market, Technology, 2018 - 2030 (USD Million)
TABLE 49 South Korea Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
TABLE 50 South Korea Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
TABLE 51 South Korea Sustained Release Excipients Market, Technology, 2018 - 2030 (USD Million)
TABLE 52 Australia Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
TABLE 53 Australia Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
TABLE 54 Australia Sustained Release Excipients Market, Technology, 2018 - 2030 (USD Million)
TABLE 55 Latin America Sustained Release Excipients Market, by Country, 2018 - 2030 (USD Million)
TABLE 56 Latin America Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
TABLE 57 Latin America Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
TABLE 58 Latin America Sustained Release Excipients Market, Technology, 2018 - 2030 (USD Million)
TABLE 59 Brazil Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
TABLE 60 Brazil Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
TABLE 61 Brazil Sustained Release Excipients Market, Technology, 2018 - 2030 (USD Million)
TABLE 62 Mexico Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
TABLE 63 Mexico Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
TABLE 64 Mexico Sustained Release Excipients Market, Technology, 2018 - 2030 (USD Million)
TABLE 65 Argentina Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
TABLE 66 Argentina Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
TABLE 67 Argentina Sustained Release Excipients Market, Technology, 2018 - 2030 (USD Million)
TABLE 68 Middle East & Africa Sustained Release Excipients Market, by Country, 2018 - 2030 (USD Million)
TABLE 69 Middle East & Africa Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
TABLE 70 Middle East & Africa Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
TABLE 71 Middle East & Africa Sustained Release Excipients Market, Technology, 2018 - 2030 (USD Million)
TABLE 72 South Africa Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
TABLE 73 South Africa Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
TABLE 74 South Africa Sustained Release Excipients Market, Technology, 2018 - 2030 (USD Million)
TABLE 75 Saudi Arabia Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
TABLE 76 Saudi Arabia Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
TABLE 77 Saudi Arabia Sustained Release Excipients Market, Technology, 2018 - 2030 (USD Million)
TABLE 78 UAE Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
TABLE 79 UAE Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
TABLE 80 UAE Sustained Release Excipients Market, Technology, 2018 - 2030 (USD Million)
LIST OF FIGURES
FIG. 1 Market research process
FIG. 2 Information Procurement
FIG. 3 Primary Research Pattern
FIG. 4 Market Research Approaches
FIG. 5 Value Chain-Based Sizing & Forecasting
FIG. 6 Market Formulation & Validation
FIG. 7 Sustained Release Excipients Market Segmentation
FIG. 8 Market Snapshot, 2021
FIG. 9 Market Trends & Outlook
FIG. 10 Market Driver Relevance Analysis (Current & Future Impact)
FIG. 11 Market Restraint Relevance Analysis (Current & Future Impact)
FIG. 12 Market Challenge Relevance Analysis (Current & Future Impact)
FIG. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
FIG. 14 Porter’s Five Forces Analysis
FIG. 15 Market Penetration Vs Growth Prospect Mapping, 2021
FIG. 16 Global Sustained Release Excipients Market: Product Movement Analysis
FIG. 17 Global Sustained Release Excipients Market, for Gelatin, 2018 - 2030 (USD Million)
FIG. 18 Global Sustained Release Excipients Market, for Polymers2018 - 2030 (USD Million)
FIG. 19 Global Sustained Release Excipients Market, for Minerals2018 - 2030 (USD Million)
FIG. 20 Global Sustained Release Excipients Market, for Sugars2018 - 2030 (USD Million)
FIG. 21 Global Sustained Release Excipients Market, for Alcohol, 2018 - 2030 (USD Million)
FIG. 22 Global Sustained Release Excipients Market, for Chitosan, 2018 - 2030 (USD Million)
FIG. 23 Global Sustained Release Excipients Market: Route of Administration Movement Analysis
FIG. 24 Global Sustained Release Excipients Market, for Oral, 2018 - 2030 (USD Million)
FIG. 25 Global Sustained Release Excipients Market, for Intramuscular, 2018 - 2030 (USD Million)
FIG. 26 Global Sustained Release Excipients Market, for Subcutaneous, 2018 - 2030 (USD Million)
FIG. 27 Global Sustained Release Excipients Market, for Transdermal, 2018 - 2030 (USD Million)
FIG. 28 Global Sustained Release Excipients Market, for Vaginal, 2018 - 2030 (USD Million)
FIG. 29 Global Sustained Release Excipients Market, for Ophthalmic, 2018 - 2030 (USD Million)
FIG. 30 Global Sustained Release Excipients Market, for Intravenous, 2018 - 2030 (USD Million)
FIG. 31 Global Sustained Release Excipients Market, for Others, 2018 - 2030 (USD Million)
FIG. 32 Global Sustained Release Excipients Market: Technology Movement Analysis
FIG. 33 Global Sustained Release Excipients Market, for Targeted Delivery, 2018 - 2030 (USD Million)
FIG. 34 Global Sustained Release Excipients Market, for Micro Encapsulation, 2018 - 2030 (USD Million)
FIG. 35 Global Sustained Release Excipients Market, for Wurster Technique, 2018 - 2030 (USD Million)
FIG. 36 Global Sustained Release Excipients Market, for Transdermal, 2018 - 2030 (USD Million)
FIG. 37 Global Sustained Release Excipients Market, for Implants, 2018 - 2030 (USD Million)
FIG. 38 Global Sustained Release Excipients Market, for Coacervation, 2018 - 2030 (USD Million)
FIG. 39 Global Sustained Release Excipients Market, for Others, 2018 - 2030 (USD Million)
FIG. 40 Regional Marketplace: Key Takeaways
FIG. 41 Regional Outlook, 2021 & 2030
FIG. 42 Global Sustained Release Excipients Market: Region Movement Analysis
FIG. 43 North America Sustained Release Excipients Market, 2018 - 2030 (USD Million)
FIG. 44 U.S. Sustained Release Excipients Market, 2018 - 2030 (USD Million)
FIG. 45 Canada Sustained Release Excipients Market, 2018 - 2030 (USD Million)
FIG. 46 Europe Sustained Release Excipients Market, 2018 - 2030 (USD Million)
FIG. 47 Germany Sustained Release Excipients Market, 2018 - 2030 (USD Million)
FIG. 48 U.K. Sustained Release Excipients Market, 2018 - 2030 (USD Million)
FIG. 49 France Sustained Release Excipients Market, 2018 - 2030 (USD Million)
FIG. 50 Italy Sustained Release Excipients Market, 2018 - 2030 (USD Million)
FIG. 51 Spain Sustained Release Excipients Market, 2018 - 2030 (USD Million)
FIG. 52 Asia Pacific Sustained Release Excipients Market, 2018 - 2030 (USD Million)
FIG. 53 Japan Sustained Release Excipients Market, 2018 - 2030 (USD Million)
FIG. 54 China Sustained Release Excipients Market, 2018 - 2030 (USD Million)
FIG. 55 India Sustained Release Excipients Market, 2018 - 2030 (USD Million)
FIG. 56 Australia Sustained Release Excipients Market, 2018 - 2030 (USD Million)
FIG. 57 South Korea Sustained Release Excipients Market, 2018 - 2030 (USD Million)
FIG. 58 Latin America Sustained Release Excipients Market, 2018 - 2030 (USD Million)
FIG. 59 Brazil Sustained Release Excipients Market, 2018 - 2030 (USD Million)
FIG. 60 Mexico Sustained Release Excipients Market, 2018 - 2030 (USD Million)
FIG. 61 Argentina Sustained Release Excipients Market, 2018 - 2030 (USD Million)
FIG. 62 Middle East and Africa Sustained Release Excipients Market, 2018 - 2030 (USD Million)
FIG. 63 South Africa Sustained Release Excipients Market, 2018 - 2030 (USD Million)
FIG. 64 Saudi Arabia Sustained Release Excipients Market, 2018 - 2030 (USD Million)
FIG. 65 UAE Sustained Release Excipients Market, 2018 - 2030 (USD Million)
FIG. 1 Market research process
FIG. 2 Information Procurement
FIG. 3 Primary Research Pattern
FIG. 4 Market Research Approaches
FIG. 5 Value Chain-Based Sizing & Forecasting
FIG. 6 Market Formulation & Validation
FIG. 7 Sustained Release Excipients Market Segmentation
FIG. 8 Market Snapshot, 2021
FIG. 9 Market Trends & Outlook
FIG. 10 Market Driver Relevance Analysis (Current & Future Impact)
FIG. 11 Market Restraint Relevance Analysis (Current & Future Impact)
FIG. 12 Market Challenge Relevance Analysis (Current & Future Impact)
FIG. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
FIG. 14 Porter’s Five Forces Analysis
FIG. 15 Market Penetration Vs Growth Prospect Mapping, 2021
FIG. 16 Global Sustained Release Excipients Market: Product Movement Analysis
FIG. 17 Global Sustained Release Excipients Market, for Gelatin, 2018 - 2030 (USD Million)
FIG. 18 Global Sustained Release Excipients Market, for Polymers2018 - 2030 (USD Million)
FIG. 19 Global Sustained Release Excipients Market, for Minerals2018 - 2030 (USD Million)
FIG. 20 Global Sustained Release Excipients Market, for Sugars2018 - 2030 (USD Million)
FIG. 21 Global Sustained Release Excipients Market, for Alcohol, 2018 - 2030 (USD Million)
FIG. 22 Global Sustained Release Excipients Market, for Chitosan, 2018 - 2030 (USD Million)
FIG. 23 Global Sustained Release Excipients Market: Route of Administration Movement Analysis
FIG. 24 Global Sustained Release Excipients Market, for Oral, 2018 - 2030 (USD Million)
FIG. 25 Global Sustained Release Excipients Market, for Intramuscular, 2018 - 2030 (USD Million)
FIG. 26 Global Sustained Release Excipients Market, for Subcutaneous, 2018 - 2030 (USD Million)
FIG. 27 Global Sustained Release Excipients Market, for Transdermal, 2018 - 2030 (USD Million)
FIG. 28 Global Sustained Release Excipients Market, for Vaginal, 2018 - 2030 (USD Million)
FIG. 29 Global Sustained Release Excipients Market, for Ophthalmic, 2018 - 2030 (USD Million)
FIG. 30 Global Sustained Release Excipients Market, for Intravenous, 2018 - 2030 (USD Million)
FIG. 31 Global Sustained Release Excipients Market, for Others, 2018 - 2030 (USD Million)
FIG. 32 Global Sustained Release Excipients Market: Technology Movement Analysis
FIG. 33 Global Sustained Release Excipients Market, for Targeted Delivery, 2018 - 2030 (USD Million)
FIG. 34 Global Sustained Release Excipients Market, for Micro Encapsulation, 2018 - 2030 (USD Million)
FIG. 35 Global Sustained Release Excipients Market, for Wurster Technique, 2018 - 2030 (USD Million)
FIG. 36 Global Sustained Release Excipients Market, for Transdermal, 2018 - 2030 (USD Million)
FIG. 37 Global Sustained Release Excipients Market, for Implants, 2018 - 2030 (USD Million)
FIG. 38 Global Sustained Release Excipients Market, for Coacervation, 2018 - 2030 (USD Million)
FIG. 39 Global Sustained Release Excipients Market, for Others, 2018 - 2030 (USD Million)
FIG. 40 Regional Marketplace: Key Takeaways
FIG. 41 Regional Outlook, 2021 & 2030
FIG. 42 Global Sustained Release Excipients Market: Region Movement Analysis
FIG. 43 North America Sustained Release Excipients Market, 2018 - 2030 (USD Million)
FIG. 44 U.S. Sustained Release Excipients Market, 2018 - 2030 (USD Million)
FIG. 45 Canada Sustained Release Excipients Market, 2018 - 2030 (USD Million)
FIG. 46 Europe Sustained Release Excipients Market, 2018 - 2030 (USD Million)
FIG. 47 Germany Sustained Release Excipients Market, 2018 - 2030 (USD Million)
FIG. 48 U.K. Sustained Release Excipients Market, 2018 - 2030 (USD Million)
FIG. 49 France Sustained Release Excipients Market, 2018 - 2030 (USD Million)
FIG. 50 Italy Sustained Release Excipients Market, 2018 - 2030 (USD Million)
FIG. 51 Spain Sustained Release Excipients Market, 2018 - 2030 (USD Million)
FIG. 52 Asia Pacific Sustained Release Excipients Market, 2018 - 2030 (USD Million)
FIG. 53 Japan Sustained Release Excipients Market, 2018 - 2030 (USD Million)
FIG. 54 China Sustained Release Excipients Market, 2018 - 2030 (USD Million)
FIG. 55 India Sustained Release Excipients Market, 2018 - 2030 (USD Million)
FIG. 56 Australia Sustained Release Excipients Market, 2018 - 2030 (USD Million)
FIG. 57 South Korea Sustained Release Excipients Market, 2018 - 2030 (USD Million)
FIG. 58 Latin America Sustained Release Excipients Market, 2018 - 2030 (USD Million)
FIG. 59 Brazil Sustained Release Excipients Market, 2018 - 2030 (USD Million)
FIG. 60 Mexico Sustained Release Excipients Market, 2018 - 2030 (USD Million)
FIG. 61 Argentina Sustained Release Excipients Market, 2018 - 2030 (USD Million)
FIG. 62 Middle East and Africa Sustained Release Excipients Market, 2018 - 2030 (USD Million)
FIG. 63 South Africa Sustained Release Excipients Market, 2018 - 2030 (USD Million)
FIG. 64 Saudi Arabia Sustained Release Excipients Market, 2018 - 2030 (USD Million)
FIG. 65 UAE Sustained Release Excipients Market, 2018 - 2030 (USD Million)
